MNPR icon

Monopar Therapeutics (MNPR)

NASDAQ

$54.90

$0.50 (

+0.91%

)

1D
5D
1M
6M
1Y
5Y
Market closed

MNPR: $54.90 / ₿ 0.0008 BTC / 83309 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$54.40
$26.06 - $105.00
$366.84M
21.18
$54.33
$113,168.80
6.68M
$17.00 - $150.00
$54.00 - $55.29
No

What is Monopar Therapeutics (MNPR)?

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

The Monopar Therapeutics (MNPR) stock price has been rising

The Monopar Therapeutics Inc. Common Stock (MNPR) stock price today is $54.90, reflecting a +0.91% move since the market opened. The company’s market capitalization stands at $366.84M, with a daily trading volume of $113.17K shares. For investors tracking price trends, Monopar Therapeutics Inc. Common Stock stock has ranged between $54.00 and $55.29 today. The previous closing price was $54.40.

Get started with Monopar Therapeutics (MNPR)

Ready to get started? Follow the steps below, or read our guide on how to buy Monopar Therapeutics stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy MNPR

Search for MNPR in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy MNPR.

MNPR FAQs

MNPR is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

MNPR is in the Biotechnology industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Monopar Therapeutics Inc. Common Stock (MNPR) has traded between a low of $26.06 and a high of $105.00.

MNPR is in the Biotechnology industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Monopar Therapeutics? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
MNPR icon
MNPR

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy Monopar Therapeutics in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

Top losers

Compare the worst-performing stocks of 
the day

OTRKQ icon

OTRKQ

YOTAR icon

YOTAR

CRESW icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.